Riskpilot← Back to searchSign inGet full accessBIOSYNTIA ApS
APSActiveCVR 34892970Fruebjergvej 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 201212 employeeshttps://www.biosyntia.com
Revenue 2024
DKK -14,1M
-21% vs 2023
EBITDA margin
176.9%
+27% vs 2023
Equity ratio
76.5%
Financial strength
Net profit 2024
DKK -18,9M
+36% vs 2023
| Revenue | DKK -14,1M | -21% |
| EBITDA | DKK -24,9M | +27% |
| Net profit | DKK -18,9M | +36% |
| Total assets | DKK 69,2M | -25% |
| Equity | DKK 52,9M | -26% |
| Employees | 12 | — |
Legal name
BIOSYNTIA ApS
CVR number
34892970
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19. december 2012
Share capital
DKK 801.859
Employees
12 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening, hvoraf den ene skal være formanden, af den samlede bestyrelse, eller af formanden i forening med en direktør.
Company purpose
Selskabets formål er at drive forskning, udvikling og produktion af biobaserede kemikalier.
Address
Fruebjergvej 3
Email
hello@biosyntia.com
Website
https://www.biosyntia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 389 | 1.578 | 1.158 | 619 | 2.198 | -2.672 | 439 | 818 | 1.167 | -16.583 | -17.798 | -14.052 |
| Staff expenses | -180 | -1.199 | -2.162 | -4.231 | -6.171 | -9.203 | -10.712 | -12.530 | -12.976 | -15.676 | -16.401 | -10.801 |
| EBITDA | -36 | -5 | -2.097 | -3.612 | -3.973 | -11.874 | -10.273 | -11.711 | -11.809 | -32.259 | -34.199 | -24.852 |
| Depreciation & amort. | -0 | -0 | -0 | -43 | -111 | -120 | -164 | -183 | -170 | -163 | -207 | -242 |
| EBIT | -36 | -5 | -2.097 | -3.655 | -4.084 | -11.994 | -10.437 | -11.894 | -11.979 | -32.422 | -34.406 | -25.094 |
| Net financials | 0 | -0 | -4 | -12 | -30 | -71 | -101 | -78 | -693 | -875 | 837 | 685 |
| Profit before tax | -36 | -5 | -2.101 | -3.667 | -4.114 | -12.066 | -10.538 | -11.972 | -12.672 | -33.297 | -33.568 | -24.409 |
| Tax | -9 | -1 | -418 | -830 | -904 | -2.635 | -2.311 | -2.620 | -2.609 | -6.862 | -4.138 | -5.500 |
| Net profit | -28 | -4 | -1.682 | -2.838 | -3.210 | -9.431 | -8.228 | -9.352 | -10.062 | -26.435 | -29.430 | -18.909 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 479 | 3.895 | 6.542 | 10.132 | 6.503 | 29.605 | 18.966 | 31.292 | 34.290 | 122.006 | 92.459 | 69.170 |
| Equity | 52 | 48 | 3.866 | 8.028 | 4.818 | 25.168 | 16.940 | 26.213 | 16.150 | 101.266 | 71.836 | 52.927 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 215 | 696 | 15.609 | 16.423 | 14.220 | 7.517 |
| Short-term debt | 426 | 3.847 | 2.676 | 2.103 | 1.686 | 4.425 | 1.811 | 4.384 | 2.531 | 4.317 | 6.403 | 8.727 |
| Total debt | 426 | 3.847 | 2.676 | 2.103 | 1.686 | 4.425 | 2.026 | 5.079 | 18.140 | 20.739 | 20.623 | 16.243 |
EBITDA margin
-2485229400.0%
This company
15.8%
Market median
-15729300100% vs market
20132024
Equity ratio
76.5%
This company
38.2%
Market median
+100% vs market
20132024
Return on equity
-35.7%
This company
18.4%
Market median
-294% vs market
20132024
Net profit margin
-1890914000.0%
This company
8.1%
Market median
-23344617384% vs market
20132024
Asset turnover
-0.20×
This company
1.12×
Market median
-118% vs market
20132024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2012-12-19 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HJ Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
MP Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
MO Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Novo Holdings A/S | Company | 33.3% | 33.3% | 2022 |
| Individual | 25.0% | 25.0% | 2022 | |
Danmarks Eksport- og Investeringsfond | Company | 10.0% | 10.0% | 2023 |
| Individual | 10.0% | 10.0% | 2022 | |
| Individual | 5.0% | 5.0% | 2022 | |
VÆKSTFONDEN | Company | 10.0% | 10.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NOVO NORDISK FONDEN
BIOSYNTIA ApS Board members of BIOSYNTIA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Jasper Genee | Chief Executive Officer | 0 companies |
| Martin Plambech | Chief Executive Officer | 0 companies |
| Morten Otto Alexander Sommer | Chief Executive Officer | 0 companies |
| Søren Knud Carlsen | Board of Directors | 0 companies |
| Thomas Grotkjær | Board of Directors | 0 companies |
| Sara Sande | Board of Directors | 0 companies |
| Henrik Dalbøge | Chairman | 0 companies |
| Søren Møller | Board of Directors | 0 companies |
| Michael Jean Nettersheim | Board of Directors | 0 companies |
| Joško Bobanović | Board of Directors | 0 companies |